Rheumatology
Conference Coverage
FVC inadequate when assessing scleroderma lung disease
Key clinical point: Patient-oriented questionnaires and lung imaging are key tools to assess systemic sclerosis patients with interstitial lung...
News
Tofacitinib bests methotrexate for RA
Key clinical point: Tofacitinib monotherapy provided better outcomes at 2 years than did methotrexate alone in patients who previously had not...
Conference Coverage
Gut inflammation linked to worsening spondyloarthritis
Major finding: Among patients with newly diagnosed spondyloarthritis, microscopic gut inflammation at baseline was linked to a two-fold higher...
Conference Coverage
International RA risk tool for CVD comes closer to reality
Key clinical point: An RA-specific calculator for 10-year CVD risk may soon be available.Major finding: The risk factors in models that used...
Conference Coverage
Sarilumab shown safe, effective for RA in phase III trial
Key clinical point: Treatment with the interleukin-6–blocking drug sarilumab showed efficacy and relative safety in the first reported results...
Conference Coverage
Different triggers found for knee and hand OA
Key clinical point: Weight loss may be a primary target for improving knee OA, but improvements in metabolic factors may most benefit hand OA....
Conference Coverage
Treat to target shows durable improvements in psoriatic arthritis
Conference Coverage
VIDEO: Micro RNA biomarkers hint at potential for predicting OA
Conference Coverage
VIDEO: Erectile dysfunction may often occur in men with gout
Conference Coverage
VIDEO: ACR, EULAR collaborate on first polymyalgia rheumatica treatment guidelines
Conference Coverage
Biosimilars match infliximab, etanercept for RA treatment
Key clinical point: Two biosimilar agents showed nearly identical efficacy, safety to infliximab and etanercept in a pair of randomized trials....